Literature DB >> 17431422

The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing.

S Papin1, S Cuenin, L Agostini, F Martinon, S Werner, H-D Beer, C Grütter, M Grütter, J Tschopp.   

Abstract

The autoinflammatory disorders Muckle-Wells syndrome, familial cold urtecaria and chronic infantile neurological cutaneous and articular syndrome are associated with mutations in the NALP3 (Cryopyrin) gene, which is the central platform of the proinflammatory caspase-1 activating complex, named the inflammasome. In patients with another autoinflammatory disorder, familial Mediterranean fever (FMF), mutations in the SPRY domain of the Pyrin protein are frequently found. Recent evidence suggests that Pyrin associates with ASC, an inflammasome component, via its Pyrin domain, thereby halting the inflammatory response. This interaction, however, does not explain the effects of mutations of the SPRY domain found in FMF patients. Here we show that the Pyrin SPRY domain not only interacts with NALP3, but also with caspase-1 and its substrate pro-interleukin(IL)-1beta. Whereas a Pyrin knockdown results in increased caspase-1 activation and IL-1beta secretion, overexpression of the SPRY domain alone blocks these processes. Thus Pyrin binds to several inflammasome components thereby modulating their activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431422     DOI: 10.1038/sj.cdd.4402142

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  122 in total

1.  The inflammasome: in memory of Dr. Jurg Tschopp.

Authors:  M Dagenais; A Skeldon; M Saleh
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 2.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 3.  Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.

Authors:  V U Ozkurede; L Franchi
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 4.  The myths we believed in familial Mediterranean fever: what have we learned in the past years?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Semin Immunopathol       Date:  2015-04-02       Impact factor: 9.623

Review 5.  COPs and POPs: modulators of inflammasome activity.

Authors:  Christian Stehlik; Andrea Dorfleutner
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

Review 6.  IL-1β biological treatment of familial Mediterranean fever.

Authors:  Alessandra Soriano; Elena Verecchia; Antonella Afeltra; Raffaele Landolfi; Raffaele Manna
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

7.  Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction.

Authors:  Peng Xu; Zongmei Wen; Xueyin Shi; Yuehua Li; Liyan Fan; Meng Xiang; Aijun Li; Melanie J Scott; Guozhi Xiao; Song Li; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

8.  Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balcı; Eray Akay; Gokhan Tumgor; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Clin Rheumatol       Date:  2019-01-31       Impact factor: 2.980

9.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

10.  The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kirikkale University in Turkey.

Authors:  Aysen Gunel-Ozcan; Derya Beyza Sayin; Emine Dibek Misirlioğlu; Sefa Güliter; Fahri Yakaryilmaz; Cuneyt Ensari
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.